Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Recent data show that corticolimbic expression of the effector immediate early gene Arc is up-regulated by standard antidepressant drugs. Here, we tested the effect upon Arc expression of a novel antidepressant and selective 5-hydroxytryptamine/noradrenaline reuptake inhibitor (SNRI), (-)1-(1-dimethylaminomethyl) 5-methoxybenzocyclobutan-1-yl) cyclohexanol (S33005). Arc mRNA abundance in frontal, cingulate, orbital and parietal cortices, hippocampus (CA1 pyramidal layer) and striatum was elevated in rats treated daily for 14 but not 7 days with 10 mg/kg i.p. S33005 compared to saline. Fourteen but not 7 days treatment with 10 mg/kg i.p. venlafaxine, the prototypical SNRI, also elevated Arc mRNA, but its effects were not as pronounced and detected in fewer regions, compared to S33005. Neither S33005 nor venlafaxine altered Arc mRNA after acute injection nor altered brain derived neurotrophic factor mRNA after repeated administration. These data demonstrate that sustained treatment with SNRIs increases Arc expression in corticolimbic regions, and underpin previous neurochemical and behavioural evidence that S33005 is efficacious in models predictive of antidepressant action.

Original publication

DOI

10.1016/j.ejphar.2004.03.002

Type

Journal article

Journal

Eur J Pharmacol

Publication Date

12/04/2004

Volume

489

Pages

179 - 185

Keywords

Animals, Antidepressive Agents, Brain-Derived Neurotrophic Factor, Cerebral Cortex, Cyclohexanols, Cytoskeletal Proteins, Drug Administration Schedule, Gene Expression, Immediate-Early Proteins, Injections, Intraperitoneal, Male, Nerve Tissue Proteins, Neurotransmitter Uptake Inhibitors, Pyramidal Cells, RNA, Messenger, Rats, Rats, Sprague-Dawley, Time Factors, Venlafaxine Hydrochloride